✦ LIBER ✦

Cotreatment with the α-glucosidase inhibitor miglitol and DPP-4 inhibitor sitagliptin improves glycemic control and reduces the expressions of CVD risk factors in type 2 diabetic Japanese patients

✍ Scribed by Imai, Chihiro; Saito, Miyoko; Mochizuki, Kazuki; Fuchigami, Masahiro; Goda, Toshinao; Osonoi, Takeshi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The α-glucosidase inhibitor miglitol dec

✍ Takeshi Osonoi; Miyoko Saito; Kazuki Mochizuki; Nanae Fukaya; Takeshi Muramatsu; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Efficacy and safety of the dipeptidyl pe

✍ Kobayashi, K.; Yokoh, H.; Sato, Y.; Takemoto, M.; Uchida, D.; Kanatsuka, A.; Kur 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

Treatment with the α-glucosidase inhibit

✍ Kazuki Mochizuki; Nanae Fukaya; Yutaro Tanaka; Masahiro Fuchigami; Toshinao Goda 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 390 KB

Serum level of soluble CD26/dipeptidyl p

✍ Yoshimasa Aso; Noriyuki Ozeki; Tomoko Terasawa; Rika Naruse; Kenji Hara; Mariko 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Twelve weeks treatment with the DPP-4 in

✍ K. Aaboe; F. K. Knop; T. Vilsbøll; C. F. Deacon; J. J. Holst; S. Madsbad; T. Kra 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 838 KB